Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america.
暂无分享,去创建一个
J. Goedert | B. Lau | R. Hogg | J. Willig | T. Sterling | A. Collier | S. Rourke | A. Justice | M. Horberg | S. Deeks | K. Gebo | A. Rachlis | C. Benson | J. Eron | M. Kitahata | B. Rodriguez | R. Harrigan | G. Kirk | A. Abraham | M. Silverberg | L. Jacobson | M. Klein | J. Gill | J. Thorne | S. Napravnik | Jinbing Zhang | R. Bosch | Jeff N. Martin | R. Mckaig | Richard D. Moore | S. J
[1] P. Harrigan,et al. Epidemiology of antiretroviral multiclass resistance. , 2010, American journal of epidemiology.
[2] Richard D Moore,et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] D. Pillay,et al. What is the risk of mortality following diagnosis of multidrug-resistant HIV-1? , 2008, The Journal of antimicrobial chemotherapy.
[4] M. Debruyne,et al. The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal , 2008, Retrovirology.
[5] A. Telenti,et al. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. , 2007, Archives of internal medicine.
[6] V. Soriano,et al. Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients. , 2007, AIDS research and human retroviruses.
[7] G. Fadda,et al. Declining Prevalence of HIV-1 Drug Resistance in Treatment-Failing Patients: A Clinical Cohort Study , 2007, Antiviral therapy.
[8] D. Kroetz,et al. Adherence-resistance relationships to combination HIV antiretroviral therapy , 2007, Current HIV/AIDS reports.
[9] J. Eron,et al. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients , 2007, AIDS.
[10] Richard D Moore,et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). , 2007, International journal of epidemiology.
[11] P. Harrigan,et al. Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART , 2006, PLoS medicine.
[12] A. Mocroft,et al. Regional Changes Over Time in Initial Virologic Response Rates to Combination Antiretroviral Therapy Across Europe , 2006, Journal of acquired immune deficiency syndromes.
[13] J. Gatell,et al. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. , 2006, Archives of internal medicine.
[14] P. Harrigan,et al. Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness , 2006, AIDS.
[15] H. Sørensen,et al. Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individuals , 2005, AIDS.
[16] G. Lucas. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. , 2005, The Journal of antimicrobial chemotherapy.
[17] P. Harrigan,et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. , 2005, The Journal of infectious diseases.
[18] A. Mocroft,et al. Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group. , 2004, The Journal of infectious diseases.
[19] R. D’Aquila,et al. Effect of Persistent Moderate Viremia on Disease Progression During HIV Therapy , 2004, Journal of acquired immune deficiency syndromes.
[20] Richard D Moore,et al. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing , 2004, AIDS.
[21] A. Levy,et al. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy. , 2004, The Journal of infectious diseases.
[22] R. Siliciano,et al. A long-term latent reservoir for HIV-1: discovery and clinical implications. , 2004, The Journal of antimicrobial chemotherapy.
[23] S. Deeks,et al. Treatment of antiretroviral-drug-resistant HIV-1 infection , 2003, The Lancet.
[24] Elizabeth Connick,et al. Antiretroviral-drug resistance among patients recently infected with HIV. , 2002, The New England journal of medicine.
[25] R. Siliciano,et al. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. , 2001, JAMA.
[26] R. Grant,et al. Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. , 2000, The Journal of infectious diseases.
[27] P. Kissinger,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. , 1998, The New England journal of medicine.
[28] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.
[29] G. Satten,et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. , 1998, The New England journal of medicine.
[30] D. Rubin. Multiple Imputation After 18+ Years , 1996 .
[31] S Greenland,et al. A critical look at methods for handling missing covariates in epidemiologic regression analyses. , 1995, American journal of epidemiology.
[32] D. Rubin,et al. Handling “Don't Know” Survey Responses: The Case of the Slovenian Plebiscite , 1995 .
[33] W Vach,et al. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. , 1991, American journal of epidemiology.
[34] Subir Ghosh,et al. Statistical Analysis With Missing Data , 1988 .
[35] D. Rubin,et al. Statistical Analysis with Missing Data , 1988 .
[36] Bryan Chan,et al. Human immunodeficiency virus reverse transcriptase and protease sequence database , 2003, Nucleic Acids Res..
[37] C. Loveday,et al. Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection , 2000 .
[38] Robert W. Shafer,et al. Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database , 1999, Nucleic Acids Res..
[39] S. Hammer,et al. Antiretroviral Drug Resistance Testing in Adult Hiv-1 Infection: 2008 Recommendations of an International Aids Society–usa Panel , 2022 .